NCT00404326View on ClinicalTrials.gov

Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

November 30, 2006

Conditions
Cervical Cancer
Interventions
DRUG

Hydralazine and magnesium valproate

PROCEDURE

Punch biopsy of the primary tumor

Trial Locations (1)

14080

National Institute of Cancerologia, Mexico City

All Listed Sponsors
collaborator

National Council of Science and Technology, Mexico

OTHER

collaborator

Psicofarma S.A. de C.V.

OTHER

lead

National Institute of Cancerología

OTHER_GOV

NCT00404326 - Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer | Biotech Hunter | Biotech Hunter